The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

Aug. 25, 2016
Applicant:

Lonza Biologics Plc., Slough, GB;

Inventors:

Robert Young, London, GB;

James D. Budge, Canterbury, GB;

Mark C. Smales, Canterbury, GB;

Assignee:

LONZA BIOLOGICS PLC., Slough, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C07K 14/005 (2006.01); C07K 16/00 (2006.01); C12N 5/071 (2010.01); C12N 7/00 (2006.01); C12N 9/12 (2006.01); C12N 15/67 (2006.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); C07K 14/005 (2013.01); C07K 16/00 (2013.01); C12N 5/0682 (2013.01); C12N 7/00 (2013.01); C12N 9/1229 (2013.01); C12N 15/67 (2013.01); C12Y 207/04004 (2013.01); C12N 2800/108 (2013.01);
Abstract

The present invention relates to an expression system for the heterologous expression of a nucleic acid sequence of interest in a mammalian cell, the system comprising: (i) a first genetic entity, comprising: a nucleic acid sequence encoding a functional Epstein Barr virus nuclear antigen 1 (EBNA-1), the nucleic acid sequence being operably linked to regulatory elements that allow for expression of the nucleic acid sequence encoding a functional EBNA-1; (ii) a second genetic entity, comprising: a nucleic acid sequence encoding a functional nucleoside diphosphate kinase A (NDPK-A), the nucleic acid sequence being operably linked to regulatory elements that allow for expression of the nucleic acid sequence encoding a functional NDPK-A; (iii) a third genetic entity, comprising: the nucleic acid sequence of interest being operably linked to regulatory elements that allow for expression of the nucleic acid sequence of interest; and (iv) a four genetic entity, comprising: the Epstein Barr virus OriP sequence or one or more subsequences thereof, wherein the one or more subsequences comprise at least the 'Family of Repeats' DNA-binding site for EBNA-1 and the 'Dyad Symmetry' DNA-binding site for EBNA-1. The present invention also relates to corresponding mammalian host cells and methods for expressing a nucleic acid sequence of interest by means of such expression system.


Find Patent Forward Citations

Loading…